COVID-19 symptoms, influenced by IL-1 and IL-6, might also occur alongside diabetes complications, although timely treatment could show elevated biomarkers in discharged patients, either without symptoms or with atypical symptoms. This evidence concerns the gene IL6 and diabetes mellitus.